Impact Of Gene Mutations On Response To Lenalidomide And Os In Lower-Risk Non-Del(5Q) Mds Patients Ineligible/Refractory To Erythropoiesis-Stimulating Agents (Esas)

AuthID
 P-00N-CER
11
Author(s)
Santini, V
·
Giagounidis, A
·
Almeida, A
·
List, AF
·
Zhong, J
·
Wu, C
·
Mavrommatis, K
·
Beach, CL
·
MacBeth, KJ
Document Type
Abstract
Year published
2017
Published
in LEUKEMIA RESEARCH, ISSN: 0145-2126
Volume: 55, Pages: S14-S14 (1)
Conference
14Th International Symposium on Myelodysplastic Syndromes (Mds), Date: MAY 03-06, 2017, Location: Valencia, SPAIN
Indexing
Wos®
Publication Identifiers
Wos: WOS:000417653300025
Source Identifiers
ISSN: 0145-2126
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service